SPC382
Dróspírenón ásamt estetróli
Status:
VeittApplication date:
7.6.2022Application published:
15.7.2022Grant published:
15.10.2025
Max expiry date:
19.5.2036Medicine name:
Drovelis; LydisilkaMedicine for children:
No
Timeline
Today
7.6.2022Application
15.7.2022Publication
15.10.2025Registration
19.5.2036Expires
Marketing license
IS authorization number:
EU/1/21/1547/001-004; EU/1/21/1548/001-004Date:
8.6.2021
Foreign authorization number:
EU/1/21/1547 & EU/1/21/1548Date:
19.5.2021
Owner
Name:
Estetra SRLAddress:
Rue Saint-Georges 5, Liege BE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP3701944
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 08.10.2025